Eva Meisenzahl

from Wikipedia, the free encyclopedia
Eva Meisenzahl (2017)

Eva Maria Meisenzahl-Lechner (* 1962 in Mainz ) is a German psychiatrist. She holds a professorship for psychiatry and psychotherapy at Heinrich Heine University in Düsseldorf and is director of the clinic and polyclinic for psychiatry and psychotherapy at Heinrich Heine University in Düsseldorf and is also the medical director of the LVR clinic in Düsseldorf .

Life

Eva Meisenzahl studied human medicine at the Medical Faculty of the University of Trieste in Italy and at the Humboldt University in Berlin . After training as a specialist in psychiatry and psychotherapy at the Theodor-Wenzel-Werk Berlin (TWW) and the Charité of the Humboldt University Berlin, she moved to the Clinic and Polyclinic for Psychiatry and Psychotherapy at the Ludwig Maximilians University in Munich (LMU) in 1996 . There she completed her habilitation in 2004 in the field of psychiatry and psychotherapy . In 2010 he was appointed to the W2 university professor for life at the Psychiatric Clinic of the Ludwig Maximilians University in Munich. In 2015, the psychiatrist was offered a full professorship for psychiatry and psychotherapy at the Christian-Albrechts University in Kiel, which she refused. Another call to the Johannes Kepler University Linz, which she also refused. In 2016, she accepted the chair for psychiatry at the Clinic and Polyclinic for Psychiatry and Psychotherapy at Heinrich Heine University Düsseldorf (HHU).

research

Her research focuses on basic clinical research into pathogenetic processes in affective and psychotic disorders as well as personality disorders of the borderline type . In addition, she deals with the diagnostic early detection and early therapy of these psychiatric disorders from adolescence. Another goal of her scientific work is to offer psychiatric diagnostics and care structures earlier and faster using e-health and telemedicine . Eva Meisenzahl is Principal Investigator of the FRP 7-funded EU research project “Personalized Prognostic Tools for Early Psychosis Management” (PRONIA). The aim of PRONIA is to extract signatures from multimodal data using AI methods to predict prognosis and diagnoses of psychiatric illnesses as well as the early detection of affective disorders.

Awards (selection)

  • 2001–2003 HWP scholarship from the Ludwig Maximilians University of Munich
  • 2002 winner of the national Bernhard-Von-Gudden Prize,
  • 2008 winner of the national Hormosan research award
  • 2011 winner of the European BMS Prevent Award of the Association of European Psychiatry (EPA).
  • 2011 Senior Research Fellow of the Bedfordshire Center for Mental Health Research at the University of Cambridge.

Publications and memberships

Eva Meisenzahl is the author of over 120 publications in international journals, including co-author of 15 specialist books. She is also a reviewer for many national and international journals. Eva Meisenzahl is a member of the German Society for Psychiatry, Psychotherapy, Psychosomatics and Neurology (DGPPN) and the European Psychiatric Association (EPA) as well as a board member of the European Scientific Association on Schizophrenia and other Psychoses (ESAS). She is also a member of the Association of Chair Holders for Psychiatry and Psychotherapy eV in Germany (LIPPs) and board member of Elan eV Düsseldorf, chairwoman of the Neurological Society of Düsseldorf and the Düsseldorf Alliance against Depression.

Web links

Individual evidence

  1. Clinic and Polyclinic for Psychiatry and Psychotherapy at HHU, LVR Clinic Düsseldorf. Retrieved October 14, 2019 .
  2. Pronia - FP7 Research Project. Retrieved October 14, 2019 .
  3. United States Patent Application: 0160192889. Retrieved November 13, 2019 .
  4. ^ Vitae of the speakers at the LVR Symposium 2019 - Conferences of the LVR Clinic Association. Retrieved October 14, 2019 .
  5. Executive Committee - ESASNET. Retrieved on October 14, 2019 (German).